Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant pleural mesothelioma

H Schouwink, P Baas, E T Rutgers

    The European Respiratory Journal
    |May 8, 1999
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Optimisation and validation of line-of-therapy advancement algorithms in advanced/metastatic non-small-cell lung cancer: an I-O Optimise study.

    ESMO real world data and digital oncology·2026
    Same author

    Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC.

    ESMO open·2026
    Same author

    Properties of CD8 T-cell-recognized neoantigens in different tumor types.

    Immuno-oncology technology·2025
    Same author

    Follow-up after first-Line nivOlumab plus ipilimumab in patients with diffuse pleuRal mesotheliomA: a real-world Dutch cohort study-FLORA.

    ESMO open·2025
    Same author

    Combined analysis of circulating tumor DNA and tumor tissue to overcome osimertinib resistance (OSIRIS); the second line osimertinib cohort.

    Lung cancer (Amsterdam, Netherlands)·2024
    Same author

    First-line doublet immunotherapy: Game changer or hype for patients with mesothelioma?

    Lung cancer (Amsterdam, Netherlands)·2024
    Same journal

    Beyond the 5th percentile: rethinking diagnostic thresholds in pulmonary function testing.

    The European respiratory journal·2026
    Same journal

    A Transcriptomic Atlas of Chronic Lung Allograft Dysfunction.

    The European respiratory journal·2026
    Same journal

    Risk of cancer and mortality in patients with interstitial lung diseases: Danish cohort study.

    The European respiratory journal·2026
    Same journal

    Proposing a minimal important difference in NTproBNP in pulmonary arterial hypertension.

    The European respiratory journal·2026
    Same journal

    Unlocking growth potential: Ivacaftor therapy and developmental gains in lung and height in a cohort study of children and young adults with cystic fibrosis.

    The European respiratory journal·2026
    Same journal

    Decoding the Lymphangioleiomyomatosis (LAM) Niche Microenvironment <i>via</i> Integrative Analysis of Single Cell Multiomics and Spatial Transcriptomics.

    The European respiratory journal·2026
    See all related articles